Related Experiment Video
Updated: Apr 22, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Controlled exosome release from the retinal pigment epithelium in situ
Christina J Locke1, Nicole R Congrove1, W Michael Dismuke2
1Department of Ophthalmology and Vision Science, University of Arizona, Tucson, AZ, USA.
Abstract:
Retinal Pigment Epithelial cells (RPE) express both GPR143 and myocilin, which interact in a signal transduction-dependent manner. In heterologous systems, activation of GPR143 with ligand causes transient recruitment of myocilin to internalized receptors, which appears to be the entry point of myocilin to the endocytic pathway. In some but not all cells, myocilin also traffics through the multivesicular body (MVB) and is released on the surface of exosomes in a signal transduction-dependent fashion. Little is known regarding the role of exosomes in RPE, but they likely serve as a mode of communication between the RPE and the outer retina. In this study, we used posterior poles with retina removed from fresh human donor eyes as a model to test the relationship between GPR143, myocilin, and exosomes in an endogenous system. We isolated exosomes released by RPE using differential centrifugation of media conditioned by the RPE for 25 min, and then characterized the exosomes using nanoparticle tracking to determine the number and size of the exosomes. Next, we tested whether ligand stimulation of GPR143 using l-DOPA altered RPE exosome release. Finally, we investigated whether myocilin was present on the exosomes released by RPE and whether l-DOPA stimulation of GPR143 caused recruitment of myocilin to the endocytic pathway, as we have previously observed using cultured cells. Activation of GPR143 halted RPE exosome release, while simultaneously recruiting myocilin to the endocytic compartment. Together, our results indicate that GPR143 and myocilin function in a signal transduction system that can control exosome release from RPE.
Insights
Retinal Pigment Epithelial cells (RPE) G protein-coupled receptor 143 (GPR143) activation halts exosome release and recruits myocilin to the endocytic pathway, revealing a novel signaling role in RPE communication.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Retinal Pigment Epithelial cells (RPE) are crucial for outer retinal health.
- RPE cells express GPR143 and myocilin, proteins known to interact via signal transduction.
- The role of exosomes in RPE-mediated communication is largely unexplored.
Purpose of the Study:
- To investigate the relationship between GPR143, myocilin, and exosome release in an endogenous RPE system.
- To determine if GPR143 activation influences RPE exosome release and myocilin localization.
- To elucidate the role of this signaling pathway in RPE exosome-mediated communication.
Main Methods:
- Utilized human donor eye posterior segments as an endogenous RPE model.
- Isolated and characterized exosomes from RPE-conditioned media using differential centrifugation and nanoparticle tracking.
- Stimulated G protein-coupled receptor 143 (GPR143) with l-DOPA and assessed its impact on exosome release and myocilin trafficking.
Main Results:
- GPR143 activation by l-DOPA halted RPE exosome release.
- Ligand stimulation of GPR143 led to the recruitment of myocilin to the endocytic compartment.
- Myocilin was detected on exosomes released by RPE cells.
Conclusions:
- GPR143 and myocilin function within a signal transduction pathway that regulates RPE exosome release.
- This interaction provides insights into RPE-mediated communication mechanisms.
- Findings suggest a novel role for GPR143 in controlling the release of signaling vesicles from RPE.
More Related Videos
10:48Rapid, Directed Differentiation of Retinal Pigment Epithelial Cells from Human Embryonic or Induced Pluripotent Stem Cells
Published on: October 30, 2017
09:46Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy
Published on: February 26, 2021